Beta Bionics, Inc.
NASDAQBBNX delivered its best stretch in months, gaining nearly 19% across the week to close at $22.81 — and the timing of a fresh Wells Fargo initiation has given that rally a narrative anchor even as shorts remain heavily positioned. Wells Fargo initiated coverage on BBNX this morning with an Overweight rating and a $28 price target, the most bullish target on the Street from a major…
BBNX short interest surges to 21.55% of float, up 20.8% in a week and 38.1% in a month, as stock falls 4.8% today.
BBNX delivered its best stretch in months, gaining nearly 19% across the week to close at $22.81 — and the timing of a fresh Wells Fargo initiation has given that rally a narrative anchor even as shorts remain heavily…
Beta Bionics enters the final week of August with its short thesis showing its first cracks: bears trimmed exposure sharply on Tuesday while the stock clawed back 1.7% on the week, yet the ORTEX short score remains…
Snapshot as of 4 Oct 2026
Beta Bionics heads into the back half of August with a striking contradiction at its core: short sellers are adding positions at their fastest rate in months, yet options traders are the most bullish they have been all…
Beta Bionics heads into late July with a notable tension at its centre: short interest has climbed nearly 47% over the past month while analysts have spent the past two weeks raising targets and initiating with bullish…
Beta Bionics heads into its July 21 earnings report with short sellers moving aggressively into the stock and Goldman Sachs lifting its target just days before the print. The short-side activity this week is the…
Beta Bionics just posted a 24% weekly gain, yet the short sellers who drove this story for months have barely moved. That tension — a sharp price recovery meeting a still-elevated short base — is the defining setup…
Beta Bionics heads into its May 21 earnings report with one of the most striking disconnects in its recent history: analysts are nearly unanimous in their bullish ratings, yet have spent months slashing the price…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for BBNX — free to start on ORTEX.
Sign up for free →Open BBNX on ORTEX